TrialJournal of neuro-oncology2010
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
David A Reardon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
125 papers cite itlatest 60 shown
this paperpooled ittrialcites it